Cervical cancer is a global killer and predominantly affects HPV unvaccinated HIV-positive women more than those who
are HIV-negative or vaccinated. The call by the WHO to eliminate cervical cancer by 2030 through targeting 90% vaccination for adolescent girls before the age of 15 years continues to yield efforts. The Human Papillomavirus (HPV) vaccine has offered a great promise to reduce the cervical cancer burden among women. However, access to HPV vaccination remains sub-optimal in Kenya due to a lack of knowledge and perceived negative opinions in the communities. This study aimed to investigate HPV vaccine uptake amongst adolescent girls 10-14 years within USAID Tujenge Jamii
(UTJ) sites.